Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Susan Collins
Pharma
Aduhelm still has big sales potential, RBC doctors' survey says
A recent doctors' survey, conducted by RBC Capital Markets, shows a strong market exists for Aduhelm, with potential for $8 billion in sales.
Kevin Dunleavy
Mar 3, 2022 2:00pm
If Trump teams with Dems, pricing bills might actually pass: analyst
Jan 14, 2019 10:46am
Democrats target drug pricing again in new economic plan
Jul 24, 2017 11:17am
Mylan plans a discounted EpiPen generic. Too little, too late?
Aug 29, 2016 9:47am
Mylan's 'cynical' EpiPen access plans trigger new outcry
Aug 26, 2016 8:50am
Hillary drug-price tweet tanks biopharma stocks again
Aug 25, 2016 11:03am
